yttrium radioisotopes has been researched along with Cancer of Intestines in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, M; Elf, AK; Henrikson, O; Jalnefjord, O; Johanson, V; Ljungberg, M; Svensson, J; Wängberg, B | 1 |
| Ćwikła, JB; Kolasińska-Ćwikła, A; Maciejkiewicz, KM; Łowczak, A | 1 |
| Colquhoun, SD; Friedman, ML; Kim, AS; Nissen, NN; Ozao-Choy, J; Wachsman, A; Wolin, EM; Yu, R | 1 |
| Banks, M; Cuthbertson, DJ; Gilbert, TM; Maltby, P; McKane, G; Palmer, DH; Poston, G; Pritchard, DM; Vinjamuri, S; Vora, J; Weissman, H | 1 |
| Bergsma, H; de Herder, WW; Kam, BL; Krenning, EP; Kwekkeboom, DJ; Peeters, RP; Teunissen, JJ; van Vliet, EI | 1 |
| Cacciari, G; Campana, D; Capurso, G; Delle Fave, G; Falconi, M; Nori, F; Panzuto, F; Partelli, S; Tamburrino, D; Tomassetti, P | 1 |
| Ardill, JE; Eatock, M; Johnston, BT; McCance, DR | 1 |
| Baete, K; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C | 1 |
| Cybulla, M; Otte, A; Weiner, SM | 1 |
| Maecke, H; Mueller-Brand, J; Schumacher, T; Waldherr, C | 1 |
| Malygina, AI; Nikitina, RG | 1 |
2 review(s) available for yttrium radioisotopes and Cancer of Intestines
| Article | Year |
|---|---|
Peptide Receptor Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors - from oncology perspective.
Topics: Humans; Intestinal Neoplasms; Lutetium; Neuroendocrine Tumors; Pancreatic Neoplasms; Radioisotopes; Receptors, Peptide; Stomach Neoplasms; Yttrium Radioisotopes | 2018 |
[Intracavitary administration of liquid radioisotopes].
Topics: Abdominal Neoplasms; Female; Gold Colloid, Radioactive; Humans; Injections, Intraperitoneal; Intestinal Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Radiotherapy; Stomach Neoplasms; Yttrium Radioisotopes | 1978 |
1 trial(s) available for yttrium radioisotopes and Cancer of Intestines
| Article | Year |
|---|---|
Radioembolization Versus Bland Embolization for Hepatic Metastases from Small Intestinal Neuroendocrine Tumors: Short-Term Results of a Randomized Clinical Trial.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Intestinal Neoplasms; Intestine, Small; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pilot Projects; Prospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2018 |
8 other study(ies) available for yttrium radioisotopes and Cancer of Intestines
| Article | Year |
|---|---|
Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Digestive System Neoplasms; Embolization, Therapeutic; Female; Humans; Intestinal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Male; Microspheres; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiography; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Peptide receptor radionuclide therapy with (90)Y-DOTATATE/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity.
Topics: Female; Humans; Intestinal Neoplasms; Intestine, Small; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Peptide; Retrospective Studies; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.
Topics: Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Retreatment; Somatostatin; Stomach Neoplasms; Yttrium Radioisotopes | 2012 |
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence.
Topics: Aged; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radiopharmaceuticals; Somatostatin; Stomach Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
Topics: Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoid Tumor; Disease Progression; Drug Monitoring; Female; Humans; Interferon-alpha; Intestinal Neoplasms; Liver Neoplasms; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Neurokinin A; Somatostatin; Yttrium Radioisotopes | 2017 |
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Topics: Adult; Disease Progression; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radioisotopes; Receptors, Peptide; Somatostatin; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
90Y-DOTATOC and nephrotoxicity.
Topics: Animals; Carcinoid Tumor; Humans; Intestinal Neoplasms; Kidney; Kidney Failure, Chronic; Octreotide; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes | 2002 |
Kidney failure after treatment with 90Y-DOTATOC.
Topics: Aged; Carcinoid Tumor; Female; Humans; Intestinal Neoplasms; Kidney Failure, Chronic; Octreotide; Radiation Injuries; Yttrium Radioisotopes | 2002 |